Related Experiment Videos
CNIO cancer conference: targeted search for anticancer drugs
1Cyclacel Limited, James Lindsay Place, Dundee, DD1 5JJ, Scotland, UK. pfischer@cyclacel.com
Abstract:
The topics discussed at the conference covered many aspects of cancer research, from the genetic search for new targets, target validation and drug discovery, all the way to preclinical and clinical development of oncology drugs. Here the presentations on new metabolic, angiogenic, cell cycle and other molecular targets, as well as recent developments with experimental drugs with action on some of these targets, are summarised. Particular emphasis is placed on the emerging realisation that changes in the metabolic phenotype lie at the heart of cellular transformation. New insights into the biological links between cancer cell metabolism and the balance between survival and death signalling are likely to lead to the identification of a new category of anticancer targets.
Insights
This conference highlighted advances in cancer research, focusing on new molecular targets and experimental drugs. A key finding is that metabolic changes are central to cancer development, offering new therapeutic targets.
Area of Science:
- Oncology and molecular biology, focusing on cancer research and drug development.
Background:
- Cancer research encompasses genetic targets, validation, drug discovery, and preclinical/clinical development.
- Key areas include metabolic, angiogenic, cell cycle, and other molecular targets.
- Experimental drugs targeting these pathways are under development.
Framework:
- The conference summarized presentations on novel molecular targets and experimental therapeutics.
- Emphasis was placed on understanding the role of metabolic phenotype in cellular transformation.
- Exploration of biological links between cancer metabolism and cell survival/death signaling.
Implementation:
- Summaries of presentations on new targets and experimental drugs.
- Focus on the central role of metabolic changes in cancer.
- Discussion of biological links between cancer cell metabolism and signaling pathways.
Implications:
- Emerging evidence suggests metabolic phenotype changes are fundamental to cancer.
- New insights into cancer cell metabolism and signaling could identify novel anticancer targets.
- Potential for a new class of anticancer drugs based on metabolic interventions.